Advanced Science Intermediate
Fatty Liver and GLP-1: The Hidden Benefit
Hepatic steatosis affects 1 in 3 Europeans. GLP-1 peptides reduce liver fat by up to 82%. Discover how TRIPLE-G acts on the liver.
13 min read
Articles tagged "retatrutide"
Explore all articles about "retatrutide": evidence-based insights, clinical studies, and GLP-1 peptide research. Updated content on GLP-1 Journal.
Peptide Comparisons Intermediate
Orforglipron vs Retatrutide: Does the Pill Beat the Triple Agonist?
Orforglipron (Eli Lilly's oral GLP-1) vs retatrutide TRIPLE-G. Pill convenience vs triple agonist efficacy: clinical data compared.
6 min read
Peptide Comparisons Intermediate
Survodutide vs Retatrutide: Dual or Triple Agonist?
Survodutide (dual GLP-1/glucagon agonist) vs retatrutide TRIPLE-G (triple agonist). Efficacy, mechanism, clinical data and results compared.
6 min read
GLP-1 Agonists Intermediate
Retatrutide: -28.7% Weight Loss — Full Guide 2026
Retatrutide targets GLP-1, GIP & Glucagon receptors. Up to -28.7% weight loss in 5,800-patient trials. Dosage, results & 2026 availability.
16 min read
GLP-1 Agonists Intermediate
What Is Retatrutide? A Complete Scientific Overview
Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.
6 min read
GLP-1 Agonists Intermediate
Retatrutide: Phase 2 and Phase 3 Clinical Trial Results
Detailed analysis of retatrutide clinical data: from the Phase 2 NEJM study to Eli Lilly's Phase 3 TRIUMPH program.
7 min read
Peptide Comparisons Intermediate
Semaglutide vs Tirzepatide vs Retatrutide: A Complete Comparison
Comparison of the three leading GLP-1 peptides: semaglutide, tirzepatide and retatrutide. Mechanism, efficacy and development status.
11 min read
Peptide Comparisons Intermediate
Best Weight Loss Peptides in 2026
Ranking of the most promising peptides for weight loss research in 2026: retatrutide, tirzepatide, semaglutide, survodutide, and CagriSema.
11 min read